AGP Picks
View all

Texas Technology Digest
Provided by AGP

Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 1, 2026

Global Memory Shortage Worsens with AI Demand as Vyrian Expands Supply of HBM, DRAM, NAND, and SSD Solutions
May 1, 2026

Global Memory Shortage Worsens with AI Demand as Vyrian Expands Supply of HBM, DRAM, NAND, and SSD Solutions

Indeterminate EIN Presswire
Reactive Media Statement
May 1, 2026

Reactive Media Statement

Indeterminate EIN Presswire
Elbit America wins U.S. Army contract to deliver next-generation binocular night vision systems
May 1, 2026

Elbit America wins U.S. Army contract to deliver next-generation binocular night vision systems

Indeterminate EIN Presswire
Any Event Productions Delivers Professional Audiovisual Production for Cato Institute Event in Austin, Texas
May 1, 2026

Any Event Productions Delivers Professional Audiovisual Production for Cato Institute Event in Austin, Texas

Indeterminate EIN Presswire
God’s Kids Curriculum Launches Pre-Sale, Expanding RightNow Media Into Children’s Ministry Space
May 1, 2026

God’s Kids Curriculum Launches Pre-Sale, Expanding RightNow Media Into Children’s Ministry Space

Indeterminate EIN Presswire
SalesCloser Secures U.S. Patent for AI-Powered Conversational Workflow Technology
May 1, 2026

SalesCloser Secures U.S. Patent for AI-Powered Conversational Workflow Technology

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Carbonara Announces Run for U.S. Congress in Florida's Redrawn 22nd District
May 1, 2026

Carbonara Announces Run for U.S. Congress in Florida's Redrawn 22nd District

Indeterminate GlobeNewswire
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
May 1, 2026

Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

Indeterminate GlobeNewswire
Fort Lauderdale Commissioner John Herbst Endorses Michael Carbonara for Congress in FL-22
May 1, 2026

Fort Lauderdale Commissioner John Herbst Endorses Michael Carbonara for Congress in FL-22

Indeterminate GlobeNewswire
Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
May 1, 2026

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Indeterminate GlobeNewswire
Trident Announces Receipt of Nasdaq Determination Letter and Intent to Request Hearing
May 1, 2026

Trident Announces Receipt of Nasdaq Determination Letter and Intent to Request Hearing

Indeterminate GlobeNewswire
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
May 1, 2026

Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation

Indeterminate GlobeNewswire
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Grants of Inducement Awards
May 1, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
May 1, 2026

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

Indeterminate GlobeNewswire
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
May 1, 2026

InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Texas Technology Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.